Eu­ro­pean reg­u­la­tors reaf­firm Apel­lis’ re­jec­tion, add eight pos­i­tive rec­om­men­da­tions

Apel­lis has had its Eu­ro­pean am­bi­tions dashed once again af­ter reg­u­la­tors reaf­firmed their de­ci­sion to not rec­om­mend the com­pa­ny’s treat­ment for ge­o­graph­ic at­ro­phy due to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.